Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites
3 clinical trials · Condition
◉ Watch Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT (NCT03435952) | M.D. Anderson Cancer Center | 2018-07-10 |
| Lenvatinib and Capecitabine in Patients With Advanced Malignancies (NCT02915172) | M.D. Anderson Cancer Center | 2016-12-01 |
Track Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites automatically
Every clearance here is in the API, with alerts when new ones post.